Updates are available Correction dated 2023-07-17
Click to view Correction: https://doi.org/10.1038/s41541-023-00703-0
-
Authors
Kim, Changyoun
Hovakimyan, Armine
Zagorski, Karen
Antonyan, Tatevik
Petrushina, Irina
Davtyan, Hayk http://orcid.org/0000-0001-8554-6456
Chailyan, Gor
Hasselmann, Jonathan
Iba, Michiyo
Adame, Anthony
Rockenstein, Edward
Szabo, Marcell http://orcid.org/0000-0002-1336-1951
Blurton-Jones, Mathew http://orcid.org/0000-0002-7770-7157
Cribbs, David H.
Ghochikyan, Anahit
Masliah, Eliezer
Agadjanyan, Michael G. http://orcid.org/0000-0002-9602-0406
- License Information
-
More Information
Article History
Received: 26 July 2021
Accepted: 24 November 2021
First Online: 10 January 2022
Change Date: 17 July 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41541-023-00703-0
Competing interests
: M.G.A. and A.G. are co-founders of Nuravax that licensed MultiTEP vaccine platform technology from the Institute for Molecular Medicine. The remaining authors declare that they have no competing interests.
